Specialty Pharmacy

Ribociclib treats patients with HR+/HER2- advanced or metastatic breast cancer.

As symptoms of depression worsen, so too does the length of survival in lung cancer patients, according to a study published in the Journal of Clinical Oncology.

Unexpected benefits seen in patients with hemophilia A when a common protein was blocked.

Fission yeast is a low cost and fast system that can improve the cancer drug discovery process.

Top news of the day from across the health care landscape.

Ustekinumab is a monoclonal antibody approved by the FDA to treat plaque psoriasis, psoriatic arthritis, and active Crohn's disease.

Rosuvastatin is the generic version of Crestor tablets from AstraZeneca.

Dolutegravir/abacavir shows a solid safety profile and a high barrier to resistance.

Specialty pharmacy relies heavily on the constantly-evolving development of new medicines and therapies.

Top news of the day from across the health care landscape.

Sheila Arquette, RPh, director of Pharmacy Services for Independent Health, discusses developments in the specialty pharmacy landscape for stakeholders to monitor.

A drug used to treat kidney cancer could be effective fighting several types of the disease.

Only 58% of breast cancer survivors received follow-up mammograms in 2007.

Few prior studies have evaluated the relative effectiveness of earlier and later lines of TNF therapy in psoriatic arthritis.

Top news of the week in oncology and cancer drug development.

Researchers found a low-cost approach to examine individual cancer cells, which could lead to a breakthrough in treatments.

Parts of a protein used in some HCV vaccine candidates are far too flexible to be successful.

Researchers seek to improve HIV drug therapies through nanomedicine.

Debiopharm International joins the Merck-Pfizer alliance for non-small cell lung cancer treatment research.

A nonsteroid anti-inflammatory drug used to treat common colds blocks bladder cancer cells from spreading in mice.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Specially compounded formulations aid patients who require medications that aren’t commercially available.

Effective specialty pharmacy patient assistance programs help patients access and remain adherent to high cost drugs.

Positive results in the KEYNOTE-045 clinical trial of Keytruda showed improved overall survival.

Top news of the day from across the health care landscape.

The widely publicized untested oncology drug scandal could lead to better clinical practice.

Catalent Pharma Solutions and Moderna Therapeutics supports manufacturing of cancer vaccines.